AI in clinical research isn’t just changing how trials are run, it’s reshaping the roles, skills, and support teams need to succeed.

In this pilot episode of Season 2, Melody Keel explores how clinical operations leaders can keep pace with AI-driven innovation while investing in the people who make trials happen

• How AI is transforming trial design, data analysis, and patient engagement
• Why traditional training approaches are failing in a tech-first environment
• What adaptive, ongoing professional development looks like in 2025
• How to lead teams through uncertainty, fear, and skill gaps
• Why culture, clarity, and curiosity matter more than ever

This episode offers real-world insight for clinical leaders balancing technological disruption with the human need for growth, stability, and purpose.

Welcome to Beyond the Protocol—where authentic conversations about clinical research happen.

Hosted by Melody Keel, bringing together diverse professionals from across the industry to share insights and experiences about what it really takes to deliver successful clinical trials.

This isn't about perfect processes—it's about real people sharing real solutions.

Let's go beyond the protocol.

That's all for today's episode of Beyond the Protocol—where we explore what it truly takes to deliver successful clinical trials.

If you found value in today's conversation, please subscribe, share with your network, and leave a review.

Have experiences or insights to share? Reach out and be part of the conversation.

Join us next week as we continue to discover what lies beyond the protocol.

You can catch it on :

📺 LinkedIn Live

📺 YouTube ▶️https://www.youtube.com/@BeyondTheProtocol

🎧 Spotify ▶️https://open.spotify.com/show/5tJlyePbEkmXLEPzSPtBcK?si=d209a257a8224056

🎧 Apple Podcasts ▶️https://podcasts.apple.com/us/podcast/beyond-the-protocol/id1798238612

🎧 Deezer ▶️https://dzr.page.link/Wy8E6rSXR7NpR15W7

🎧 Podcast address ▶️https://beyondtheprotocol.buzzsprout.com/

This Podcast is Sponsored by The Research Associate Group, Inc.